Welcome

REMICADE® (infliximab) at janssenaccessone.com is designed to provide access to reimbursement information and support services for health care professionals and their patients.

Provider Resources

Billing

Billing

Provides state-specific information for all key areas of reimbursement.

References

References

Listing of documentation and reference material to help guide health care professionals through the reimbursement process.

AccessOne®

AccessOne®

Single-source support for access to infusion therapy for REMICADE®.

AccessOne® Video

eBIF Submission

eBIF Submission

Access to the electronic benefit investigation process.

Indications & Important Safety Information

Indications & Important Safety Information

Links to the full Prescribing Information and Medication Guide.

Patient Assistance

Patient Assistance

Patient Assistance

Your patients may be eligible for these prescription assistance and affordability options.

REMICADE® (infliximab) is marketed by Janssen Products, LP.

July 17, 2014